Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cellular Pharmacology and Platelet Effects of Abacavir and Lamivudine Anabolites

NCT04301661 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT04301661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04301661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cellular Pharmacology and Platelet Effects of Abacavir and Lamivudine Anabolites
Lead sponsor
University of Colorado, Denver
Phase
Observational
Overall status
Completed
Start date
March 6, 2020
Completion date
December 17, 2021
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection